Improving the performance of culture-based bacterial screening by increasing the sample volume from 4 mL to 8 mL in aerobic culture bottles

Transfusion

Volumn 52, Issue 7, 2012, Pages 1576-1582

  Souza, Stephanie ^a   Bravo, Marjorie ^a   Poulin, Terri ^a   Vanderpool, Sandra ^a   Kamel, Hany ^a   Tomasulo, Peter ^a   Su, Leon L ^a  

^a Blood Systems Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC CULTURE BOTTLE; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD ANALYSIS; BLOOD BANK; BLOOD SAMPLING; BLOOD VOLUME; CONTROLLED STUDY; GLASS BOTTLE; HUMAN; SAMPLE SIZE;

AEROBIOSIS; BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; BLOOD PLATELETS; HUMANS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84863802238     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03489.x     Document Type: Article

References (14)

1. American Association of Blood Banks. Standards for blood banks and transfusion services. 27th ed. Bethesda (MD): American Association of Blood Banks; 2011.
2. de Korte D, Curvers J, de Korte W, Hoekstra T, van der Poel CL, Beckers EA, Marcelis JH,. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006; 46: 476-85.
3. Satake M, Mitani T, Oikawa S, Nagumo H, Sugiura S, Tateyama H, Awakihara S, Mitsutomi Y, Muraoka M, Tadokoro K,. Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan. Transfusion 2009; 49: 2152-7.
4. Eder AF, Kennedy JM, Dy BA, Notari EP, Skeate R, Bachowski G, Mair DC, Webb JS, Wagner SJ, Dodd RY, Benjamin RJ,; American Red Cross Regional Blood Centers. Limiting and detecting bacterial contamination of apheresis platelets: in-line diversion and increased culture volume improve component safety. Transfusion 2009; 49: 1554-63.
5. US Food and Drug Administration. Fatalities reported to the FDA following blood collection and transfusion. Annual summary for fiscal year 2010. Rockville (MD): Food and Drug Administration; 2010. [cited 2011 Dec 6]. Available from: URL: http://www.fda.gov/biologicsbloodvaccines/ safetyavailability/reportaproblem/transfusiondonationfatalities/ucm254802.htm
6. Pearce S, Rowe GP, Field SP,. Screening for platelets for bacterial contamination of the Welsh Blood Service. Transfus Med 2011; 21: 25-32.
7. Jacobs MR, Good CE, Lazarus HM, Yomtovian RA,. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008; 46: 1214-20.
8. Dumont LJ, Kleinman SH, Murphy JR, Lippincott R, Schuyler R, Houghton J, Metzel P,. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010; 50: 589-99.
9. Palavecino EL, Yomtovian RA, Jacobs MR,. Bacterial contamination of platelets. Transfus Apher Sci 2010; 42: 71-82.
10. Kleinman S, Dumont LJ, Tomasulo P, Bianco C, Katz L, Benjamin RJ, Gajic O, Brecher ME,. The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments. Transfusion 2009; 49: 903-12.
11. Su L, Kamel H, Custer B, Vanderpool S, Harpool D, Busch M, Tomasulo P,. Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture system. Transfusion 2008; 48: 1842-52.
12. Wagner SJ, Eder AF,. A model to predict the improvement of automated blood culture bacterial detection by doubling platelet sample volume. Transfusion 2007; 47: 430-3.
13. Kleinman SH, Kamel HT, Harpool DR, Vanderpool SK, Custer B, Wiltbank TB, Nguyen KA, Tomasulo PA,. Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion 2006; 46: 1787-94.
14. Martinez F, Tarrand J, Lichtiger B,. Impact on patient outcome following transfusion of bacterially contaminated platelets: the MD Anderson Cancer Center experience. Am J Clin Pathol 2010; 134: 207-12.